Skip to main content

The Link Between Constipation and Semaglutide Use in Patients with Overweight or Obesity

 



The Link Between Constipation and Semaglutide Use in Patients with Overweight or Obesity


Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has been heralded as a game-changer in the management of obesity. While its efficacy in promoting weight loss is well-documented, there is an emerging conversation within the medical community about its gastrointestinal side effects, particularly constipation. This article aims to provide health professionals with a comprehensive understanding of the evidence linking semaglutide to constipation and its implications on gut health.

Understanding Semaglutide
Semaglutide is a once-weekly injectable medication that mimics the functions of the natural hormone GLP-1. It works by enhancing insulin secretion, inhibiting glucagon release, and slowing gastric emptying. These mechanisms collectively contribute to appetite suppression and significant weight loss. However, the slowing of gastric emptying can also lead to gastrointestinal discomfort, including constipation.

The Evidence
A pivotal study by Wharton et al. (2022) found that gastrointestinal tolerability is a significant concern for patients on semaglutide. The study, which included adults with overweight or obesity, reported that a substantial number of participants experienced gastrointestinal adverse events (AEs). Among these, constipation was notably prevalent. The researchers concluded that while semaglutide is effective for weight loss, its gastrointestinal AEs could impact the quality of life and adherence to treatment.

Another comprehensive review by Iqbal et al. (2022) further corroborated these findings. This meta-analysis examined the effects of GLP-1 receptor agonists, including semaglutide, on body weight in adults with obesity but without diabetes. Although the primary focus was on weight loss, the study highlighted that gastrointestinal AEs, such as constipation, were common across various trials. These adverse events necessitate a balanced discussion between healthcare providers and patients about the benefits and potential drawbacks of semaglutide use.

The Microbiome Connection
Beyond simple discomfort, constipation can have a profound impact on the gut microbiome. The gut microbiome plays a crucial role in overall health, influencing everything from immune function to mental health. Chronic constipation can disrupt the delicate balance of gut bacteria, leading to dysbiosis. This imbalance may exacerbate gastrointestinal symptoms and potentially undermine the overall effectiveness of weight loss interventions.

Implications for Healthcare Providers
Given the compelling evidence, it is imperative for healthcare providers to have informed conversations with their patients about the potential side effects of semaglutide. Here are a few key points to consider:
  1. Patient Education: Ensure that patients are fully aware of the potential for gastrointestinal side effects, including constipation. Discuss strategies for managing these symptoms, such as dietary adjustments and supplements. 
  2. Monitoring and Follow-Up: Regularly monitor patients for signs of gastrointestinal distress. Early intervention can prevent more severe complications and improve adherence to treatment.
  3. Integrative Approach: Consider incorporating integrative health strategies to support gut health. Colon hydrotherapy, probiotics, and other gut-friendly interventions can help maintain a balanced microbiome and mitigate the effects of constipation.

Conclusion
While semaglutide offers significant benefits for weight loss, healthcare providers must be vigilant about its gastrointestinal side effects, particularly constipation. The relationship between semaglutide use and constipation underscores the need for a holistic approach to patient care, one that considers both the benefits and potential drawbacks of treatment. By staying informed and proactive, healthcare
professionals can help their patients achieve their weight loss goals while maintaining optimal gut health.

Join our community dedicated to integrative health and wellness. Sign up for health tips and educational opportunities to stay updated on the latest in gut health management.




References
Wharton S, Calanna S, Davies M, et al. Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight loss. Diabetes Obes Metab. 2022;24(1):94-105. doi: 10.1111/dom.14551

Iqbal J, Wu HX, Hu N, et al. Effect of glucagon-like peptide-1 receptor agonists on body weight in adults with obesity without diabetes mellitus-a systematic review and meta-analysis of randomized control trials. Obesity Reviews. 2022;23(6):e13435. doi:https://doi.org/10.1111/obr.13435


Take the first step today. Book a 15-minute Nutrition Consult with Wendy Today. 

Comments

Post a Comment

Popular posts from this blog

Where Do Gut Issues Come From

  Where Do Gut Issues Come From Introduction: A Question Without a Simple Answer As a colon hydrotherapist, nutritionist, and educator, one of the most common questions I hear is: “How did I end up with these gut issues?” Constipation, bloating, IBS, inflammation—it often feels like they appeared out of nowhere. But the truth is: gut dysfunction is rarely sudden. It is layered, complex, and influenced by a constellation of physical, emotional, and environmental factors. What I know today as a practitioner may evolve tomorrow. That’s the beauty—and challenge—of science. But what remains constant is this: the gut is the center of our health , and understanding its roots can unlock powerful healing. In this article, I’ll walk you through some of the key contributing factors to gut dysfunction—many of which I explore in my book RYSE From Within: A Guide to Heal Your Gut —and the science behind how they shape our digestive health. 1. Genetics: The Blueprint—but Not the Destiny Som...
Post a Comment
Read more
  Navigating Travel Constipation: Tips for Maintaining Digestive Health on the Go Traveling—whether for leisure or business—can be exhilarating, but for many, it also disrupts a crucial part of daily wellness: regular bowel movements.  Travel constipation is a common yet often overlooked condition that affects both frequent flyers and occasional vacationers.  Understanding its causes and implementing preventive strategies can help support gut health, ensuring your journey is as comfortable as it is memorable. What Causes Travel Constipation? Constipation during travel is typically multifactorial. The primary contributing factors include: Changes in routine : Our digestive system thrives on regularity. Travel often alters meal times, sleep schedules, and bathroom habits, disrupting the body’s natural rhythm (Staller, 2017). Dehydration : Long flights, hot climates, and increased caffeine or alcohol intake can lead to fluid loss, reducing the wa...
Post a Comment
Read more

A Functional Medicine Approach to SIBO and Methane Overgrowth

  A Functional Medicine Approach to SIBO and Methane Overgrowth Small Intestinal Bacterial Overgrowth (SIBO) and its methane-dominant form—now termed Intestinal Methanogen Overgrowth (IMO)—are key contributors to chronic digestive complaints such as bloating, constipation, and abdominal discomfort. While conventional treatment often relies on symptom suppression or singular pharmaceutical approaches, the functional medicine model aims to uncover the root causes behind these overgrowths and restore balance to the gut ecosystem. By integrating advanced testing, targeted nutrition, herbal antimicrobials, and motility support, this approach provides both relief and resilience.   Understanding SIBO and Methane Overgrowth SIBO is characterized by an abnormal increase in the population of bacteria in the small intestine, typically resulting from impaired motility, post-infectious changes, or structural anomalies. In contrast, IMO is caused by an overgrowth of archaea, such as Methan...
Post a Comment
Read more